SCHEMBL20857033

SCHEMBL20857033

CC(=O)Nc1cccc(C(=O)N2CCC(N(C(=O)CCl)c3ccccc3)CC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.49
RAB9A P51151 2/20 0.49
MITF O75030 2/20 0.49
ALDH1A1 P00352 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 1/20 0.49
NPC1 O15118 1/20 0.49
PAX8 Q06710 1/20 0.49
GABRD O14764 1/20 0.48
GABRA1 P14867 1/20 0.48
GABRB1 P18505 1/20 0.48
GABRA5 P31644 1/20 0.48
GABRA3 P34903 1/20 0.48
GABRA2 P47869 1/20 0.48
GABRB2 P47870 1/20 0.48
GABRA4 P48169 1/20 0.48
OPRD1 P41143 3/20 0.46
OPRM1 P35372 2/20 0.46
CRBN Q96SW2 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19687605 0.85 MITF (0.54) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL18763050 0.84 MITF (0.64) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL18763041 0.80 MITF (0.51) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL20857035 0.80 MITF (0.66) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL20857060 0.78 KMO (0.52) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL18770884 0.77 MITF (0.71) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL7231708 0.76 FAAH (0.62) KMT2AALDH1A1SMN1; SMN2MEN1HTT
SCHEMBL3121243 0.75 MEN1 (0.55) KMT2ARAB9AMITFALDH1A1SMN1; SMN2
SCHEMBL18792902 0.75 OPRM1 (0.65) OPRD1OPRM1SIGMAR1
SCHEMBL18478351 0.73 HPGD (0.69) KMT2AALDH1A1MEN1GABRDGABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF SCRIPPS RESEARCH INST (US) 2020-09-03 US disclosed
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF SCRIPPS RESEARCH INST (US) 2020-09-03 US disclosed
EP-3688472-A1 CONJUGATED PROTEINS AND USES THEREOF The Scripps Research Institute (US) 2020-08-05 EP disclosed
WO-2019067741-A1 CONJUGATED PROTEINS AND USES THEREOF THE SCRIPPS RESEARCH INSTITUTE (US) 2019-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200278355-A1 CONJUGATED PROTEINS AND USES THEREOF KEAP1, GSTK1, GSTM2 KMT2A 3092/4885RAB9A 2876/4885MITF 978/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.